Navigation Links
Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower

The Food and Drug Administration (FDA) has granted approval to Mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering from severe chronic pain that cannot be managed with alternative analgesics. When applied to the skin, this patch technology delivers fentanyl, an opioid pain medication that is slowly absorbed into the body through the skin providing pain relief for up to three days (72 hours).

The agency's approval is expected to provide patients with access to a lower cost alternative of this pain management system. At the same time that FDA approved Mylan's generic product, it acted on several citizens' petitions requesting that FDA deny or delay approval of the product.

The original Fentanyl Transdermal System was approved in August 1990. It is currently approved for the management of chronic pain in patients who require continuous opioid analgesia for pain that cannot be managed by acetaminophen-opioid combinations, non-steroidal analgesics, or as needed dosing with short-acting opioids.

Fentanyl is currently a Schedule II controlled substance, which is the highest level of control for drugs with a recognized medical use. As a controlled substance in Schedule II of the Controlled Substances Act (CSA), Fentanyl also comes under the jurisdiction of the Drug Enforcement Administration (DEA), which administers the CSA. Schedule II drugs are subject to manufacturing quotas set by DEA with input on medical need from FDA, distribution tracking, import and export controls, registration of prescribers and dispensers, and written prescriptions without refills.


'"/>

Source:


Page: 1

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2019)... ... February 01, 2019 , ... ... Clinical Testing Laboratories by A2LA, which establishes requirements for medical laboratories to demonstrate ... laboratory is already CLIA-licensed as well as College of American Pathologists (CAP)-accredited, a ...
(Date:1/25/2019)... ... January 24, 2019 , ... ... with rare diseases , As states continue to grapple with prescription drug costs, ... and disease-specific questions policy makers should address before deciding whether to contract with ...
(Date:1/20/2019)... ... January 16, 2019 , ... ... a medical research platform that uses artificial intelligence (AI) and a data-centric approach ... Crohn’s disease and ulcerative colitis. , People will Crohn’s or other chronic medical ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... ... Lifecycle since 2016. In his position as Director of Sales and Marketing, Mr. ... services supplier across multiple industries the company supports. During this time, Mr. Schieving ...
(Date:1/30/2019)... , ... January 30, 2019 , ... ... from pharma, academia and governmental agencies to discuss best practices for laboratory automation ... February 4-6. , At this year’s conference, Visikol will be at booth ...
(Date:1/24/2019)... ... January 22, 2019 , ... Controlled Contamination Services is pleased to announce ... Each of these valuable new team members will support its growing operation across the ... as CCS scales its business. This addition will enable CCS to widen its reach ...
(Date:1/21/2019)... ... January 21, 2019 , ... ... line, SporActiv™, for the industrial and institutional cleaning market. MDG’s SporActiv liquid and ... commercial cleaning needs. Applications include odor control, floor and tile cleaners, carpets, drains, ...
Breaking Biology Technology: